A research study in Colombia to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illness
- Conditions
- Patients with severe mental illness (including psychosis, bipolar disorder and severe depression)Mental and Behavioural Disorders
- Registration Number
- ISRCTN83333181
- Lead Sponsor
- Queen Mary University of London
- Brief Summary
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 11/08/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 173
1. Primary diagnosis of severe mental illness (psychosis, bipolar disorder and/or severe depression) ICD F20-29, F31, F32
2. Aged 18-65 years old
3. Attending clinic for at least 6 months
4. Scores 5 or below on the MANSA scale
5. Capacity to provide informed consent
1. Does not meet inclusion criteria
2. Primary diagnosis of substance-use disorder
3. Diagnosis of dementia or organic psychosis
4. An inpatient at the time of recruitment
5. Participating in another study being conducted by this or another research group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA) measured at baseline, 6 months (post intervention) and 12 months
- Secondary Outcome Measures
Name Time Method <br> Measured at baseline, 6 months (post intervention) and 12 months:<br> 1. Objective social functioning, measured with the objective social outcome index (SIX)<br> 2. Symptoms, measured with the Brief Psychiatric Rating Scale (BPRS)<br> 3. Service use, measured with adapted Client Service Receipt Inventory (CSRI)<br>